8 June 2021
Braveheart Investment Group plc
(the "Company")
Block admission six monthly return
Braveheart Investment Group (AIM: BRH), announces the following information in connection with its block admission pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies.
Further to the announcement on 3 December 2020 regarding the block admission of 766,138 ordinary shares of 2p each in the Company ("Ordinary Shares")("the Block Admission"), which became effective on 8 December 2020, a total of 766,138 Ordinary Shares were issued following the exercise of warrants on 8 December 2020.
Accordingly, all the Ordinary Shares the subject of the Block Admission have been issued and there are no outstanding unissued Ordinary Shares.
Name of company:
| Braveheart Investment Group plc |
Name of scheme:
| Warrants granted in conjunction with the placing announced on 1 May 2020 |
Period of return:
| From 8 December 2020 to 8 June 2021 |
Number and class of securities not issued under the scheme at the beginning of the period: | 766,138 ordinary shares of 2 pence each in the Company (the "Ordinary Shares")
|
Number of securities issued under the scheme during the period:
| 766,138 Ordinary Shares
|
Balance under the scheme of securities not yet issued at the end of the period:
| 0 (Nil) Ordinary Shares |
Number and class of securities originally admitted and the date of admission:
| 766,138 Ordinary Shares on 8 December 2020 |
Contact name and telephone number:
| Trevor Brown, Chief Executive Officer 01738 587555
|
For further information:
| |
Braveheart Investment Group plc | Tel: 01738 587555 |
| |
Trevor Brown CEO | |
| |
Allenby Capital Limited (Nominated Adviser and Joint Broker) | Tel: 020 3328 5656 |
David Worlidge / James Reeve / George Payne | |
| |
Peterhouse Capital Limited (Joint Broker) | Tel: 020 7469 0936 |
Heena Karani / Lucy Williams | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.